Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias

Berglund, Eva ; Barbany, Gisela ; Orsmark-Pietras, Christina LU ; Fogelstrand, Linda ; Abrahamsson, Jonas ; Golovleva, Irina ; Hallböök, Helene ; Lazarevic, Vladimir LU ; Levin, Lars Åke and Nordlund, Jessica , et al. (2022) In Frontiers in Medicine 9. p.1-9
Abstract

Background: Whole-genome sequencing (WGS) and whole-transcriptome sequencing (WTS), with the ability to provide comprehensive genomic information, have become the focal point of research interest as novel techniques that can support precision diagnostics in routine clinical care of patients with various cancer types, including hematological malignancies. This national multi-center study, led by Genomic Medicine Sweden, aims to evaluate whether combined application of WGS and WTS (WGTS) is technically feasible and can be implemented as an efficient diagnostic tool in patients with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). In addition to clinical impact assessment, a health-economic evaluation of such strategy... (More)

Background: Whole-genome sequencing (WGS) and whole-transcriptome sequencing (WTS), with the ability to provide comprehensive genomic information, have become the focal point of research interest as novel techniques that can support precision diagnostics in routine clinical care of patients with various cancer types, including hematological malignancies. This national multi-center study, led by Genomic Medicine Sweden, aims to evaluate whether combined application of WGS and WTS (WGTS) is technically feasible and can be implemented as an efficient diagnostic tool in patients with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). In addition to clinical impact assessment, a health-economic evaluation of such strategy will be performed. Methods and Analysis: The study comprises four phases (i.e., retrospective, prospective, real-time validation, and follow-up) including approximately 700 adult and pediatric Swedish AML and ALL patients. Results of WGS for tumor (90×) and normal/germline (30×) samples as well as WTS for tumors only will be compared to current standard of care diagnostics. Primary study endpoints are diagnostic efficiency and improved diagnostic yield. Secondary endpoints are technical and clinical feasibility for routine implementation, clinical utility, and health-economic impact. Discussion: Data from this national multi-center study will be used to evaluate clinical performance of the integrated WGTS diagnostic workflow compared with standard of care. The study will also elucidate clinical and health-economic impacts of a combined WGTS strategy when implemented in routine clinical care. Clinical Trial Registration: [https://doi.org/10.1186/ISRCTN66987142], identifier [ISRCTN66987142].

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
author collaboration
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
acute lymphoblastic leukemia, acute myeloid leukemia, clinical utility, diagnostic efficiency, health-economic evaluation, technical feasibility, whole-genome sequencing, whole-transcriptome sequencing
in
Frontiers in Medicine
volume
9
article number
842507
pages
1 - 9
publisher
Frontiers Media S. A.
external identifiers
  • pmid:35402448
  • scopus:85130851065
ISSN
2296-858X
DOI
10.3389/fmed.2022.842507
language
English
LU publication?
yes
additional info
Publisher Copyright: Copyright © 2022 Berglund, Barbany, Orsmark-Pietras, Fogelstrand, Abrahamsson, Golovleva, Hallböök, Höglund, Lazarevic, Levin, Nordlund, Norèn-Nyström, Palle, Thangavelu, Palmqvist, Wirta, Cavelier, Fioretos and Rosenquist.
id
68d86b85-4910-4a80-8363-e0eadd2bb330
date added to LUP
2022-06-05 15:06:45
date last changed
2022-08-09 19:46:40
@article{68d86b85-4910-4a80-8363-e0eadd2bb330,
  abstract     = {{<p>Background: Whole-genome sequencing (WGS) and whole-transcriptome sequencing (WTS), with the ability to provide comprehensive genomic information, have become the focal point of research interest as novel techniques that can support precision diagnostics in routine clinical care of patients with various cancer types, including hematological malignancies. This national multi-center study, led by Genomic Medicine Sweden, aims to evaluate whether combined application of WGS and WTS (WGTS) is technically feasible and can be implemented as an efficient diagnostic tool in patients with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). In addition to clinical impact assessment, a health-economic evaluation of such strategy will be performed. Methods and Analysis: The study comprises four phases (i.e., retrospective, prospective, real-time validation, and follow-up) including approximately 700 adult and pediatric Swedish AML and ALL patients. Results of WGS for tumor (90×) and normal/germline (30×) samples as well as WTS for tumors only will be compared to current standard of care diagnostics. Primary study endpoints are diagnostic efficiency and improved diagnostic yield. Secondary endpoints are technical and clinical feasibility for routine implementation, clinical utility, and health-economic impact. Discussion: Data from this national multi-center study will be used to evaluate clinical performance of the integrated WGTS diagnostic workflow compared with standard of care. The study will also elucidate clinical and health-economic impacts of a combined WGTS strategy when implemented in routine clinical care. Clinical Trial Registration: [https://doi.org/10.1186/ISRCTN66987142], identifier [ISRCTN66987142].</p>}},
  author       = {{Berglund, Eva and Barbany, Gisela and Orsmark-Pietras, Christina and Fogelstrand, Linda and Abrahamsson, Jonas and Golovleva, Irina and Hallböök, Helene and Lazarevic, Vladimir and Levin, Lars Åke and Nordlund, Jessica and Norèn-Nyström, Ulrika and Palle, Josefine and Thangavelu, Tharshini and Palmqvist, Lars and Wirta, Valtteri and Cavelier, Lucia and Fioretos, Thoas and Rosenquist, Richard}},
  issn         = {{2296-858X}},
  keywords     = {{acute lymphoblastic leukemia; acute myeloid leukemia; clinical utility; diagnostic efficiency; health-economic evaluation; technical feasibility; whole-genome sequencing; whole-transcriptome sequencing}},
  language     = {{eng}},
  pages        = {{1--9}},
  publisher    = {{Frontiers Media S. A.}},
  series       = {{Frontiers in Medicine}},
  title        = {{A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias}},
  url          = {{http://dx.doi.org/10.3389/fmed.2022.842507}},
  doi          = {{10.3389/fmed.2022.842507}},
  volume       = {{9}},
  year         = {{2022}},
}